Enanta Pharmaceuticals, Inc.ENTANASDAQ
LOADING
|||
EPS Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
29.93%
↑ 291% above average
Average (9y)
-15.68%
Historical baseline
Range
High:274.19%
Low:-176.37%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| 2025 | 29.93% |
| 2024 | 14.11% |
| 2023 | -7.95% |
| 2022 | -50.77% |
| 2021 | -116.57% |
| 2020 | -176.37% |
| 2019 | -31.90% |
| 2018 | 274.19% |
| 2017 | -18.42% |
| 2016 | -73.05% |